Why this matters: Janus Living is flashing three distinct signals at once. Short positions have surged 52% in a month. The put/call ratio spiked to a 52-week high. Yet the borrow market remains wide open, and analysts keep lifting targets. The signals point in different directions — and that's the story.
Seven firms have raised price targets on JAN since early August. Scotiabank lifted its target to $31 on September 2. Wells Fargo went to $35 the day before. Barclays moved to $34. The consensus target sits at $34, against a current price of $30.70 — implying roughly 10.7% upside.
None of those firms changed their ratings. All maintained Overweight or equivalent calls.
Short sellers disagree. Shares short rose from 4.7 million in late July to 7.1 million as of September 2 — a 52% jump in roughly five weeks. The build arrived in two distinct waves: first around August 10, then again around August 25. The ORTEX short score has moved from 42.8 to 46.5 in parallel. Still mid-range, but directionally higher.
The options market added a wrinkle this week. The put/call ratio hit 0.0332 on August 27-28 — the highest reading in 52 weeks, and 2.3 standard deviations above its 20-day mean. That was a clear defensive signal.
By September 2, the PCR had collapsed back to 0.0084 — near the 52-week low. The spike appears to have been short-lived. Whether it was hedging activity that expired or unwound, or simply thin options volume moving the ratio, the current reading no longer reflects the same defensive tone.
One thing that hasn't changed: shorting JAN is easy and cheap. Availability sits at 1,675% — meaning there are roughly sixteen shares available to lend for every one already borrowed. Cost to borrow fell 80% over the past week to just 0.40%. The lending market offers bears no friction and imposes no squeeze risk.
That's the clearest constraint on the short thesis. A large, sustained short build in a stock with this much borrow availability and this low a cost to borrow is not self-reinforcing — there's no mechanism that forces short covering.
See the live data behind this article on ORTEX.
Open JAN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
